PHASE 1 CLINICAL TRIAL FOR A NOVEL, ORALLY AVAILABLE THERAPEUTIC THAT ADDRESSES NOISE-INDUCED HEARING LOSS

$2,123,064FY2012Department of DefenseDOD

Hough Ear Institute, Oklahoma City OK

Investigators

PHASE 1 CLINICAL TRIAL FOR A NOVEL, ORALLY AVAILABLE THERAPEUTIC THAT ADDRESSES NOISE-INDUCED HEARING LOSS · GrantIndex